the mahogany trial: emerging roles for btkis in indolent lymphoma
Published 9 months ago • 112 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:16
controversies surrounding the management and treatment of lymphomas
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
3:33
the growing role of machine learning in hematological oncology
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
21:06
lymphoid series part 1
-
1:46:07
hematology lecture
-
2:31
relevance trial analysis: investigating the impact of lymphocyte/monocyte ratio on patient outcomes
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma
-
1:06
derive trial update: did vs dvd in newly diagnosed mm
-
0:45
difference between quality of life & patient-reported outcomes
-
0:56
promising combinations being explored for idh1 & idh2-mutated aml
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
0:57
the potential of the tsafinder tool in hematological oncology
-
2:41
an overview of the latest advances in hematology
-
1:12
clinical implications of extramedullary manifestations in cmml